Medicines Co. (MDCO) Posts Surprise Q1 Profit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Basic earnings per common share: -1.23
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Basic earnings per common share: -1.23
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q1 adjusted EPS of $0.08, $0.92 better than the analyst estimate of ($0.84). Revenue for the quarter came in at $126.5 million versus the consensus estimate of $138.78 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Preferred Bank (PFBC) Tops Q3 EPS by 4c
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
